Methylphenidate Hydrochloride (la) Capsule, Extended Release
Product Images NDC 75907-049

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (la) (NDC 75907-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp 60mg Carton (Meth 04)

This text provides information about a medication called Methylphenidate Hydrochloride capsules in an extended-release form. It specifies the dosage of 60 mg and indicates that it should be taken once daily. The text also mentions that it comes in a package with 30 capsules. Additionally, there is a note for pharmacists to dispense the medication along with the Medication Guide. This medication is available from Dr. Reddy's.*

FDA Label Image

Pdp-10mg Carton (Meth 05)

This is a description of extended-release capsules containing Methylphenidate Hydrochloride. The usual dosage instructions can be found on the package insert. The capsules should be stored at 25°C (77°F) with excursions permitted to 15-30°C (59-86°F). It is important to store this medication and all drugs out of the reach of children. The product is distributed by Dr. Reddy's Laboratories, Inc. For any inquiries, you can contact 1-888-375-3784. This specific product is labeled with NDC76907-049-01 and includes 100 capsules for prescription use only.*

FDA Label Image

Pdp 20mg Carton (Meth 06)

This text is a details of an extended-release capsule medication containing 20mg Methylphenidate Hydrochloride, USP. It is stored at controlled room temperature and should be kept out of reach of children. The medication is produced by Reddy's Laboratories, Inc. in Princeton, NJ. For more information, there is a contact number provided.*

FDA Label Image

Pdp 30mg Carton (Meth 07)

Each extended-release capsule contains Methylphenidate Hydrochloride, USP 30mg. The usual dosage should be followed as per the package insert. Store the medication at 25°C (77°F) with excursions permitted from 15° to 30°C (59° to 86°F) as indicated in the USP guidelines. Keep all drugs out of children's reach. These capsules are distributed by Reddy's under the brand name REVIVZS. This medication is for once-daily use and should be dispensed by a pharmacist with the provided Medication Guide. Each pack contains 100 capsules.*

FDA Label Image

Pdp 40mg Carton (Meth 08)

Each Extended-Release Capsule Contains Methylghenidate Hydrochorde 40 mg. This medication is for once daily use and is a pharmacist-dispensed product. It is advised to store the capsules at 25°C with excursions permitted to 15-30°C. The product should be kept in a tight container out of reach of children. For further information or questions, contact Dr. Reddy's Laboratories Inc. at the provided contact number.*

FDA Label Image

Chemical Structure (Methylphenidate 01)

FDA Label Image

Figure 1 (Methylphenidate 02)

Not available.*

FDA Label Image

Principal Display Panel (Methylphenidate 03)

This is a data table showing the comparison between Mathylphenidate HCI ER Capsules and Placebo groups in a study. The data includes mean values for different test scores with error bars indicating the standard error of the mean. The Mathylphenidate HCI ER Capsules group had 63 participants, and the Placebo group had 71 participants.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.